Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes

Background Kidney graft survival has never been systematically compared between Europe and the United States. Methods Applying period analysis to first deceased-donor (DD) and living-donor kidney grafts from the United Network for Organ Sharing/Organ Procurement and Transplantation Network for the United States and the Collaborative Transplant Study for Europe, we compared overall and age-specific 1-, 5-, and 10-year graft survival for Europeans and white, African, and Hispanic Americans for the 2005 to 2008 period. A Cox regression model was used to adjust for differences in patient characteristics. Results For the 2005 to 2008 period, 1-year survival for DD grafts was equal (91%) between Europeans and white and Hispanic Americans, whereas it was slightly lower for African Americans (89%). In contrast, overall 5- and 10-year graft survival rates were considerably higher for Europe (77 and 56%, respectively) than for any of the three U.S. populations (whites, 71 and 46%, Hispanic, 73 and 48%, and African American, 62 and 34%). Differences were largest for recipient ages 0 to 17 and 18 to 29 and generally increased beyond 3 to 4 years after transplantation. Survival patterns for living-donor grafts were similar as those seen for DD grafts. Adjusted hazard ratios for graft failure in United Network for Organ Sharing white Americans ranged between 1.5 and 2.3 (all P<0.001) for 2 to 5 years after transplantation, indicating that lower graft survival is not explained by differences in baseline patient characteristics. Conclusions Long-term kidney graft survival rates are markedly lower in the United States compared with Europe. Identifying actionable factors explaining long-term graft survival differences between Europe and the United States is a high priority for improving long-term graft survival.

[1]  P. Roderick,et al.  Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review , 2004, Transplantation.

[2]  H. Brenner,et al.  Up-to-date long-term survival curves of patients with cancer by period analysis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H Brenner,et al.  Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. , 2004, European journal of cancer.

[4]  H. Brenner,et al.  American Journal of Epidemiology Practice of Epidemiology from Cancer to Transplantation: an Evaluation of Period Analysis for Calculating Up-to-date Long-term Survival Estimates , 2022 .

[5]  M. Schnitzler,et al.  Income‐Related Disparities in Kidney Transplant Graft Failures Are Eliminated by Medicare's Immunosuppression Coverage , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  T. Burroughs,et al.  Health insurance considerations for adolescent transplant recipients as they transition to adulthood , 2007, Pediatric transplantation.

[7]  B. Kasiske,et al.  Payment for immunosuppression after organ transplantation , 2000 .

[8]  R. Ettenger,et al.  Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants. , 2004, Transplantation.

[9]  J. Kalbfleisch,et al.  Access and Outcomes Among Minority Transplant Patients, 1999–2008, with a Focus on Determinants of Kidney Graft Survival , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  M. Tonelli,et al.  Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation. , 2012, The New England journal of medicine.

[11]  N. Pallet,et al.  Kidney Transplant in Black Recipients: Are African Europeans Different from African Americans? , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Hermann Brenner,et al.  Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis , 2002, The Lancet.

[13]  C. Sima,et al.  Similar outcomes among black and white renal allograft recipients. , 2009, Journal of the American Society of Nephrology : JASN.

[14]  M. Benfield Insurance, non‐adherence – A call to action , 2007, Pediatric transplantation.

[15]  Christopher T. Erb,et al.  Prescription noncompliance due to cost among adults with disabilities in the United States. , 2002, American journal of public health.

[16]  J. Lewsey,et al.  Survival after liver transplantation in the United Kingdom and Ireland compared with the United States , 2007, Gut.

[17]  H. Brenner,et al.  Advanced detection of time trends in long-term cancer patient survival: experience from 50 years of cancer registration in Finland. , 2002, American journal of epidemiology.

[18]  B. Kasiske,et al.  Payment for immunosuppression after organ transplantation. American Society of Transplantation. , 2000, JAMA.

[19]  H Brenner,et al.  A computer program for period analysis of cancer patient survival. , 2002, European journal of cancer.

[20]  M. Schnitzler,et al.  Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  H. Brenner,et al.  Period Analysis for More Up-to-Date Graft and Patient Survival Estimates in Transplantation: An Evaluation Using United Network for Organ Sharing Data , 2010, Transplantation.